Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1188300.RAfEeaBvv-lZftqtteC4N39PGqQsxxB5x0_ptWdS8d2xQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1188300.RAfEeaBvv-lZftqtteC4N39PGqQsxxB5x0_ptWdS8d2xQ130_assertion type Assertion NP1188300.RAfEeaBvv-lZftqtteC4N39PGqQsxxB5x0_ptWdS8d2xQ130_head.
- NP1188300.RAfEeaBvv-lZftqtteC4N39PGqQsxxB5x0_ptWdS8d2xQ130_assertion description "[For this purpose, the MTOR, S6K1 (RPS6KB1), and 4EBP1 (EIF4EBP1) mRNA expression were evaluated in ten NAs, ten adrenal hyperplasias (AHs), 17 adrenocortical adenomas (ACAs), and 17 ACCs by qPCR, whereas total(t)/phospho(p)-MTOR, t/p-S6K, and t/p-4EBP1 protein expression were assessed in three NAs, three AHs, six ACAs, and 20 ACCs by immunohistochemistry.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1188300.RAfEeaBvv-lZftqtteC4N39PGqQsxxB5x0_ptWdS8d2xQ130_provenance.
- NP1188300.RAfEeaBvv-lZftqtteC4N39PGqQsxxB5x0_ptWdS8d2xQ130_assertion evidence source_evidence_literature NP1188300.RAfEeaBvv-lZftqtteC4N39PGqQsxxB5x0_ptWdS8d2xQ130_provenance.
- NP1188300.RAfEeaBvv-lZftqtteC4N39PGqQsxxB5x0_ptWdS8d2xQ130_assertion SIO_000772 24891456 NP1188300.RAfEeaBvv-lZftqtteC4N39PGqQsxxB5x0_ptWdS8d2xQ130_provenance.
- NP1188300.RAfEeaBvv-lZftqtteC4N39PGqQsxxB5x0_ptWdS8d2xQ130_assertion wasDerivedFrom befree-2016 NP1188300.RAfEeaBvv-lZftqtteC4N39PGqQsxxB5x0_ptWdS8d2xQ130_provenance.
- NP1188300.RAfEeaBvv-lZftqtteC4N39PGqQsxxB5x0_ptWdS8d2xQ130_assertion wasGeneratedBy ECO_0000203 NP1188300.RAfEeaBvv-lZftqtteC4N39PGqQsxxB5x0_ptWdS8d2xQ130_provenance.